Psoriasis vulgaris is the most common form of psoriasis. It causes patches of scaly, inflamed skin and can occur across the body. Vulgaris is Latin for ‘common’, so it means a common form of psoriasis ...
A low-fat diet has likewise received favorable recognition in the treatment of psoriasis. Grütz and Bürger, 12 the originators of this therapy, concluded that psoriasis was a "lipoidosis" and that a ...
Plaque psoriasis is the most common type of psoriasis — a group of skin conditions that affect the skin and cause itchy rashes and pain. Plaque psoriasis causes raised red or purple patches covered ...
GUANGZHOU, China--(BUSINESS WIRE)--HiST Pharma through its wholly-owned Psoriasis Research Institute of Guangzhou (PRIG) announces today that the U.S. Food and Drug Administration (FDA) has approved ...
Ten-year mean costs associated with psoriasis-related health care visits were 10 times higher for patients with generalized pustular psoriasis (GPP). Patients with generalized pustular psoriasis (GPP) ...
To address this intriguing question, Egeberg and colleagues used the Danish National Patient Register to gather data from Danish adults (age >18 years) over a 14-year period (n = 5,379,859). This deep ...
Have there been any reports in the literature linking improvement of psoriasis vulgaris with initiation of long-term, low-dose aspirin therapy, even when usual therapy has failed? I have seen marked ...
Higher disease acceptance in patients with psoriasis is linked to better outcomes, underscoring the need for psychological resilience in treatment. The study found illness acceptance negatively ...
Knight obtained the Canadian rights to WYNZORA ® through its June 2025 acquisition of the assets of Paladin Pharma Inc. (“Paladin”). In November 2024, Paladin had entered into a license agreement with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results